A treatment for dry eye—a burning, gritty condition that can impair vision and damage the cornea—could some day result from computer simulations that map the way tears move across the surface of the ...
With the singular exception of punctal or canalicular occlusion, when we are talking about in-office dry eye disease ...
Dry eye syndrome can cause various symptoms, including pain, stinging, and blurred vision. Over-the-counter (OTC) medications such as artificial tears and prescription eye drops can help manage ...
InvestorsHub on MSN
Aldeyra receives FDA rejection for dry eye treatment reproxalap
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...
If home remedies and artificial tears aren’t adequately addressing your dry eye symptoms, a doctor may recommend a medical device or procedure in addition to at-home treatments. Dry eye syndrome ...
Millions of people suffer from dry eye disease, frequently due to meibomian gland dysfunction (MGD). According to Dr. April Jasper of Advanced Eye Care Specialists, “Dry eye disease occurs when tears ...
I’ve never been the town crier. But in the last two years, my manly, tough-guy cheeks have been wetter than a Lesley Gore album. Remember Lesley, that cute little girl from Tenafly with the great big ...
Sponsored Content: Dry Eye Treatment Center of Connecticut – Revolutionizing Dry Eye Treatment in CT
NEW HAVEN, Conn. (WTNH) – On a recent edition of “CT BUZZ”, Reporter Jillian Andrews spoke with Dr. Donald Higgins, Optometrist and Medical Director of the Dry Eye Treatment Center of Connecticut, to ...
Burning, itching, watering eyes. Few things are a bigger nuisance than irritated eyes, so it's no surprise there are so many options for dry eye relief. While various treatment options are available ...
In its complete response letter, the FDA said Aldeyra had failed to demonstrate reproxalap’s efficacy in adequate and ...
Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results